Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.84 USD
Change Today +0.07 / 1.86%
Volume 414.8K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald M. Green Ph.D.

Chairman of Ethics Advisory Board,Ocata Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Ronald M. Green, Ph. D serves as Chairman of Ethics Advisory Board at Advanced Cell Technology Inc. Prof. Green has been a Member of Dartmouth’s Religion Department since 1969. Prof. Green also directs Dartmouth’s Ethics Institute, whose mission is to further teaching and research in applied and professional ethics. In 1996 and 1997, Prof. Green served as Director of the Office of Genome Ethics at the National Human Genome Research Institute of the National Institutes ...

Read Full Background

Corporate Headquarters*

33 Locke Drive
Marlborough, Massachusetts 01752

United States

Phone: 508-756-1212
Fax: 508-229-2333

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1973
Harvard University
Unknown/Other Education
Brown University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCAT:US $3.84 USD +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$884.3K
Olav Hellebo Chief Executive Officer and Director
ReNeuron Group plc
225.0K GBP
David M. Pernock Chairman, Chief Executive Officer and President
Fibrocell Science, Inc.
$490.0K
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, General Counsel and Director
Neuralstem, Inc.
$651.2K
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$469.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCATA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.